Investor · McKinney, TX

Robert Byrnes

Open Robert in the network graph →

Filings

15

SEC Form D

Connections

35

co-filers

Capital

$450K

across filings

Active

Feb 2011

to Dec 2019

Most-connected co-filers (35)

Phyllis Gardner · Newark, CA13 shared Jim E. Glasheen · San Diego, CA13 shared L. D. Browne · Newark, CA12 shared Frank J. Kung · Palo Alto, CA12 shared Vicente Trelles · Newark, CA11 shared Dan Beecroft · Boca Raton, FL10 shared Richard Teal · Austin, TX10 shared Daniel M. Teal · Austin, TX10 shared Blake Beecroft · Boca Raton, FL10 shared Toney Jennings · Horseshoe Bay, TX10 shared Joel R. Beaudin · North River, NY9 shared Ron Eastman · San Diego, CA7 shared Jan H. Steenbrugge · Boston, MA4 shared Jonathan E. Tunnicliffe · Raleigh, NC4 shared Gregory J. Petro · Sewickley, PA4 shared Stephen V. Campe · Sunnyvale, CA2 shared Arthur J. Benvenuto · Durham, NC2 shared Patrick R. Wethington · MARLBOROUGH, MA2 shared George B. Bashforth · Camana Bay, Grand Cayman, Cayman Islands2 shared Ronald M. Nelson · Brooklyn Park, MN2 shared David B. Springer · Brooklyn Park, MN2 shared Kurt Wheeler · Brooklyn Park, MN2 shared James Garvey · Brooklyn Park, MN2 shared John O'Mahony · Brooklyn Park, MN2 shared

Recent filings (15)

A1 Health Group, LLCDec 2019 · 5 co-filers$450K A1 Health Group, LLCDec 2019 · 5 co-filers$450K Revance Therapeutics, Inc.Oct 2013 · 14 co-filers$30.0M Revance Therapeutics, Inc.Feb 2013 · 15 co-filers$60.0M Revance Therapeutics, Inc.Jan 2013 · 15 co-filers$63.4M Revance Therapeutics, Inc.Sep 2012 · 15 co-filers$50.9M Revance Therapeutics, Inc.Oct 2011 · 7 co-filers$1.2M Revance Therapeutics, Inc.Oct 2011 · 7 co-filers$1.2M Revance Therapeutics, Inc.Jun 2011 · 13 co-filers$45.0M NOVELLUS RESEARCH SITES INCFeb 2011 · 7 co-filers$725K NOVELLUS RESEARCH SITES INCFeb 2011 · 7 co-filers$725K Revance Therapeutics, Inc.Feb 2011 · 13 co-filers$15.0M Revance Therapeutics, Inc.Nov 2010 · 11 co-filers$36.2M Revance Therapeutics, Inc.Aug 2010 · 11 co-filers$34.4M Revance Therapeutics, Inc.Jun 2010 · 11 co-filers$33.4M CHF SOLUTIONS INCJan 2010 · 15 co-filers$2.3M Revance Therapeutics, Inc.Dec 2009 · 11 co-filers$25.6M CHF SOLUTIONS INCOct 2009 · 15 co-filers$1.1M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Robert in the interactive graph →